Market Movers Today: Akorn, Inc. (AKRX), Akcea Therapeutics Inc (AKCA), Macy’s Inc (M), AutoZone, Inc. (AZO), and More
What happened: Shares of Akorn, Inc.
Posts Tagged ‘Akorn Inc (AKRX)’
Why Akorn, Inc. (AKRX) Shares Rallied on Monday
After surging sharply on Friday, Akorn, Inc.
What Is Happening In Financial Markets Today?
"U.S. equities advanced slightly on Monday amid geopolitical tensions while investors looked ahead to the start of earnings season.
Why Akorn, Inc. (AKRX) Shares Spiked Higher
Akorn, Inc. (NASDAQ:AKRX) shares have surged 18% on Friday after Bloomberg reported that its sources say Fresenius SE 'is weighing a bid' to buy Akorn.
Here’s What Is Going On In The Financial Markets Today?
"Stocks rose slightly on Friday afternoon as investors parsed through a mixed employment report, a U.S. airstrike in Syria and comments from a top Federal Reserve official.
Billionaire John Paulson Boosts Stakes in Endo Pharmaceuticals, Akorn; Plus Top Three New Positions
Famous for his bet against subprime mortgages at the height of the US housing bubble, John Paulson was just another hedge fund manager prior to that.
Five Big Winners in Today’s Trading Session Include Biotech with Promising Drug That Cures Ebola-like Virus
U.S equities inched lower in early trading this morning following twin deadly attacks on Brussels' Zaventem airport and a metro train in the Belgian capital.
Activist Tom Sandell’s Newest Targets
Sandell Asset Management is a hedge fund that was founded in 1998 by activist investor Tom Sandell, who is currently the fund’s manager.
Top New Picks of Healthcare Fund Blue Jay Capital: Endo International plc (ENDP), Alkermes Plc (ALKS), Akorn Inc. (AKRX)
Healthcare-focused fund Blue Jay Capital Management, managed by Paul Sinclair, has disclosed its equity portfolio for the reporting period of March 31 in a 13F filed with the ...
Akorn, Inc. (AKRX), United Therapeutics Corporation (UTHR) Among Consonance Capital’s Winning Bets in Healthcare
The $5.50 billion pharmaceutical company Akorn, Inc. (NASDAQ:AKRX) was one of the top gainers on Wednesday, closing the session with an almost 10% gain.
Do Hedge Funds and Insiders Love Akorn, Inc. (AKRX)?
To many of your peers, hedge funds are viewed as useless, old investment tools of an era lost to time.
Akorn, Inc. (AKRX), Hi-Tech Pharmacal Co. (HITK): The New Leader in Ophthalmology
This space has a bright future outlook, and according to Markets and Markets, it is projected to reach a market size of $36 billion by 2014, increasing at a CAGR of 5.4% during...
Hedge Funds Are Betting On Momenta Pharmaceuticals, Inc. (MNTA)
Now, according to many market players, hedge funds are assumed to be bloated, outdated investment tools of a period lost to current times.
This Metric Says You Are Smart to Buy Sagent Pharmaceuticals Inc (SGNT)
If you were to ask many of your fellow readers, hedge funds are seen as useless, old investment tools of a forgotten age.
Why Akorn, Inc. (AKRX) and Hi-Tech Pharmacal Co. (HITK)’s Shares Soared
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Is Salix Pharmaceuticals, Ltd. (SLXP) Going to Burn These Hedge Funds?
In the 21st century investor’s toolkit, there are dozens of methods shareholders can use to monitor their holdings.
Do Hedge Funds and Insiders Love Mylan Inc. (MYL)?
To many investors, hedge funds are assumed to be overrated, old financial vehicles of an era lost to time.
Hedge Funds Are Crazy About Ligand Pharmaceuticals Inc. (LGND)
At the moment, there are dozens of methods investors can use to monitor the equity markets. Some of the most useful are hedge fund and insider trading interest.
Viropharma Inc (VPHM), Actavis Inc (ACT), Akorn, Inc. (AKRX): Can This Experimental Drug Be Brought Back From the Dead?
Five years ago, Viropharma Inc (NASDAQ:VPHM) had everything going for it.
This Metric Says You Are Smart to Sell Akorn, Inc. (AKRX)
Akorn, Inc. (NASDAQ:AKRX) was in 8 hedge funds' portfolio at the end of March. AKRX shareholders have witnessed a decrease in enthusiasm from smart money recently.
Sagent Pharmaceuticals Inc (SGNT): Hedge Funds and Insiders Are Bearish, What Should You Do?
If you'd ask most investors, hedge funds are viewed as unimportant, old financial tools of yesteryear.
3 Earnings Reports That Caught My Attention Last Week: Akorn, Inc. (AKRX), Clean Energy Fuels Corp. (CLNE)
As first-quarter earnings begin to wind down, I can't help but point out that the majority of earnings reports we've covered over the past year have been better than expected.
